but few of these studies examine the prevalence of cholesterol embolism. Flory examined histological sections from 267 necropsies and found that 3 4% of the cases had cholesterol emboli33; all these cases had been selected because the necropsy had shown "advanced arteriosclerosis" in the aorta. Other series with selected cases coming to necropsy include one restricted to subjects older than 60 years37 and another on subjects who had had arteriographic procedures.42 Maurizi et al looked at 100 consecutive necropsies and found that four contained cholesterol emboli in the lower extremities, 40 but this is a North American study and was performed 23 years ago so it may not be relevant to a British population today.
Some estimate of the prevalence of cholesterol embolism is useful in the interpretation of biopsy specimens: a single cholesterol embolus in a vessel of a renal biopsy specimen would be of little relevance if such embolism was common, but if cholesterol embolism was rare then it would have to be regarded as a possible cause of the renal dysfunction. Preston et al reported 14 cases of cholesterol emboli in a series of 334 renal biopsy specimens from patients older than 65 years," but all these patients had renal failure before biopsy. Disseminated cholesterol embolism has been recognised as the cause of disease after identification in biopsy material45" but these patients had clinical features, such as livedo reticularis, which provided confirmatory evidence. This study aimed to examine a large, apparently unbiased, sample of histological specimens taken at necropsy to produce an estimate of the current prevalence of cholesterol embolism in Britain.
Methods
The histological material from all necropsies performed at the Royal Hallamshire Hospital between 1987 and 1990 was reviewed. Cases with a slide of the spleen and each kidney were used in the study. The haematoxylin and eosin stained slides of these organs were screened at a final magnification of x 100 for the presence of cholesterol emboli using the histological features described by Kennedy43 as criteria for identification. In cases where cholesterol Cross Fibrous tissue surrounding two cholesterol-crystal-shaped clefts in the lumen of an artery in the kidney (elastic van Gieson).
necropsy was recorded. The age distribution of the total necropsy population was compared with those necropsies with histology using the Mann-Whitney U test; the sex distribution of these two groups was examined using the x2 test.
Results Necropsies (n = 1838) were performed during the study period on 1038 men (56%) and 800 women (44%) with a mean age of 66-5 years (range 10-99 years). Three hundred and seventy-two of these necropsies had slides of the spleen and both kidneys; 212 (57%) were from men and 160 (43%) from women with a mean age of 66 4 years (range 17-92 years). Cholesterol emboli (figure) were identified in nine cases (2-4% of those cases with appropriate histological material). The age distributions of these populations are given in table 1. There was no significant difference Discussion This is a retrospective study and so there are potential problems with bias in the sample of necropsies which had appropriate histology available. The selection of histological material was made by individual pathologists with no agreed sampling protocol, so it is possible that the cases with two slides of kidneys and one of spleen differed from the overall population of necropsies, but there was no significant difference in the age or sex distribution of the two populations. The causes of death in the two groups could not be compared as no suitable analytical framework could be devised. Much of the data from this study confirm the features of cholesterol embolism reported previously."'1 Most (8/9) of subjects were male and all were older than 60. Lesions of differing ages were found in individual cases, suggesting that the process of embolism was recurrent. It was not possible to grade the degree of aortic atheroma from the subjective evaluation available in the necropsy reports, but most descriptions included the presence of extensive ulcerated atherosclerotic plaques. The overall prevalence of cholesterol embolism in the kidneys and spleen in this study (2-4%) is lower than that found in the study by Maurizi (4%) . 4 That study included biopsy specimens of the lower extremities which could have increased the number of cases detected, but 24 of the 25 cases had cholesterol emboli in the kidneys, 15 had emboli in the spleen, and all cases had emboli in either the kidneys or spleen. The prevalence in subjects 60 years and older in this study (3 4% ) is much lower than the 17-6% reported by Gore,37 a North American series performed 30 years ago. In Gore's study 12 of the 13 cases had emboli in the kidneys and 10 had emboli in the spleen. Two of the positive cases in this study had had left heart catheterisation four weeks before death, this is well recognised inciting factor for cholesterol embolism.2426 If these cases are excluded then the prevalence of "spontaneous" cholesterol embolism in this study is 1-9%, which is lower than that of previous studies, and may indicate a lower prevalence of cholesterol embolism in Britain compared with North America or a decrease in prevalence over the past two decades. This low prevalence might suggest that cholesterol embolism in biopsy material is a clinically important finding, but the causes of death in this study do not support this. Three of the subjects died with myocardial infarction, and the cholesterol embolism could be regarded as a marker of severe atherosclerosis; the other deaths were from a variety of causes with no apparent relation with cholesterol embolism.
The main conclusion of this study is that cholesterol embolism is rare, even in selected populations such as subjects older than 60, but its clinical importance can be assessed only in conjunction with other clinical information.
